Dec 18, 2016

Turning therapeutic antibodies inside-out to fight cancer

Posted by in categories: biotech/medical, life extension, neuroscience

More progress on the cancer front! Controlling cancer effectively is a critical part of rejuvenation biotechnology and therefore all cancer progress is of great interest to our community. If there was a poster child of aging diseases, cancer would be at the front of the queue.

“The results could lead to new treatments—not only for a variety of cancers, but also other diseases that arise from faulty proteinases, such as Alzheimer’s, asthma, multiple sclerosis and arthritis.”

Read more

Comments are closed.